Article: Product: Lybrel.(New Drug Information)(Drug overview)

COMPANY: Wyeth

PHARMACOLOGIC CLASS: Oral contraceptive (progestin + estrogen)

ACTIVE INGREDIENTS: Levonorgestrel 0.09mg, ethinyl estradiol 20 micrograms (28 tabs).

INDICATION: Oral contraception.

PHARMACOLOGY: Lybrel is a non-cyclic oral contraceptive product that is given every day, without a hormonefree interval. Rather than experiencing withdrawal bleeding on a monthly basis, patients using Lybrel do not have regular menstrual cycles. However, unscheduled bleeding and spotting may occur.

CLINICAL TRIALS: The safety and efficacy of Lybrel were evaluated in 2 one-year trials. The first study, which was a one-year open-label ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!